AC
IDXX icon

Aaron Cowen’s Idexx Laboratories IDXX Stock Holding History

Aaron Cowen’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-920
Closed -$511K – 105
2023
Q4 		$511K Hold
920
– – 0.02% 83
2023
Q3 		$402K Hold
920
– – 0.02% 85
2023
Q2 		$462K Hold
920
– – 0.02% 94
2023
Q1 		$460K Hold
920
– – 0.02% 88
2022
Q4 		$375K Buy
+920
New +$357K 0.02% 79

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aaron Cowen's IDXX Position: Q1 2024 in Review

Aaron Cowen sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 920 shares — an estimated $511K sold.

Aaron Cowen first reported a position in IDXX in Q4 2022 and held it in 5 quarters. The position peaked at $511K in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Aaron Cowen reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • Aaron Cowen sold 920 Idexx Laboratories shares in Q1 2024, an estimated $511K.
  • Aaron Cowen first reported a position in Idexx Laboratories in Q4 2022 and held it in 5 quarters.
  • Aaron Cowen's Idexx Laboratories position peaked at $511K in Q4 2023.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Suvretta Capital Management's 13F filing for Q1 2024, filed 15 May 2024.